awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36155239-1D2C09C7-5274-43DC-AC1C-6BF2DF897480
Q36155239-1D2C09C7-5274-43DC-AC1C-6BF2DF897480
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36155239-1D2C09C7-5274-43DC-AC1C-6BF2DF897480
JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
P2860
Q36155239-1D2C09C7-5274-43DC-AC1C-6BF2DF897480
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36155239-1D2C09C7-5274-43DC-AC1C-6BF2DF897480
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b84f43aa613fd05cdf5a147a412717e2486b500
P2860
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.